Astria Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Astria Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Astria Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $100K, unchanged year-over-year.
  • Astria Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $1M, a 42.9% increase year-over-year.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $1M, a 42.9% increase from 2023.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $700K, a 12.5% decline from 2022.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $800K, a 14.3% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1M +$300K +42.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $700K -$100K -12.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $800K +$100K +14.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 $700K -$800K -53.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $1.5M +$100K +7.14% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $1.4M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.